AXSYM CORE 2.0 AND AXSYM CORE 2.0 CONTROLS

FDA Premarket Approval P060012

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the axsym core 2. 0 and axsym core 2. 0 controls. This device is indicated for: the axsym core 2. 0 is a microparticle enzyme immunoassay (meia) intended for the qualitative detection of total antibodies (igg and igm) to hepatitis b virus core antigen (anti hbc) in adult and pediatric serum (including serum collected in serum separator tubes) or plasma (collected in potassium edta, sodium citrate, sodium heparin, lithium heparin, or plasma separator tubes containing lithium heparin). The assay is used as an aid in the diagnosis of acute, chronic, or resolved hepatitis b virus (hbv) infection in conjunction with other laboratory results and clinical information. The the axsym core 2. 0 controls are used for monitoring the performance of the axsym system (reagent and instrument) when used for the qualitative detection of total antibodies to hepatitis b virus core antigen (anti hbc) when using the axsym core 2. 0 reagent kit. The performance of the axsym core 2. 0 controls has not been established with any other anti-hbc assays.

DeviceAXSYM CORE 2.0 AND AXSYM CORE 2.0 CONTROLS
Generic NameTest, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm)
ApplicantABBOTT LABORATORIES INC
Date Received2006-03-24
Decision Date2006-09-08
Notice Date2007-04-19
PMAP060012
SupplementS
Product CodeLOM 
Docket Number07M-0153
Advisory CommitteeMicrobiology
Expedited ReviewNo
Combination Product No
Applicant Address ABBOTT LABORATORIES INC 100 Abbott Park Road ap5n-2, Dept. 09vb abbott Park, IL 60064
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P060012Original Filing
S010 2012-11-13 30-day Notice
S009 2011-11-02 135 Review Track For 30-day Notice
S008 2011-09-07 Special (immediate Track)
S007 2011-03-21 135 Review Track For 30-day Notice
S006 2011-01-31 Normal 180 Day Track No User Fee
S005 2010-11-01 Normal 180 Day Track No User Fee
S004 2010-09-27 30-day Notice
S003 2010-09-21 30-day Notice
S002 2010-05-19 30-day Notice
S001 2007-01-17 30-day Notice

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.